Skip to main content
. 2023 Apr 18;24:155. doi: 10.1186/s12859-023-05268-2

Fig. 8.

Fig. 8

Construction and validation of a prognostic model in lung adenocarcinoma (LUAD). A Survival analysis of TP53 mutation. B Nomogram. C, D Prediction curve of 3-year survival and 5-year survival of LUAD patients with NOMO model. E Univariate COX Analysis. F Multivariate COX Analysis